Video blogger and mother of three Kristin Moras had a particularly tumultuous start to 2020. The coronavirus pandemic meant that in early spring she suddenly found herself homeschooling her two sons while pregnant with her third child. Not only were the stress and pregnancy hormones causing her skin to flare, but she wasn’t able to take her prescribed medications for rosacea because of her pregnancy.
New Rosacea Survey Shows Most Patients Are Satisfied With Therapy, But More Awareness of Treatment Options Is Needed
A recent National Rosacea Society (NRS) survey found that most rosacea patients were satisfied with the oral and topical prescription therapies they are using to treat this chronic facial skin disorder, but that individuals 60 and over were more likely to use older treatments, rather than newer products that may more
A recent NRS survey revealed that most rosacea patients are impacted psychologically by the disease and its effect on their appearance, but treatment may lessen rosacea’s negative effects.
The following announcement was issued by Galderma Laboratories, L.P.:
National Campaign Empowers 16 Million Americans Faced with a Chronic Inflammatory Skin Condition to Take Action, Navigate Treatment Journey with a Dermatologist
Walking and hiking are great ways to exercise and enjoy the best that nature has to offer this summer. While social distancing may prevent many rosacea patients from visiting gyms or taking part in organized sporting events, it’s easy to walk and hike independently or in a safely distanced group. Unfortunately, it’s also easy to overlook the potential for a rosacea flare-up while walking for exercise.
New developments in rosacea call for dermatologists to place greater emphasis on addressing persistent facial redness (erythema), according to experts at a recent National Rosacea Society (NRS) roundtable to provide an update on this key aspect of the disorder, based on the new standard classification system, recent burden-of-illness study results, new standard management options and significant advances in medical t
Every person is host to a natural mix of bacteria, fungi and viruses — they are normal inhabitants of the skin, known as the skin microbiome. But the makeup of that community may be very different in those with rosacea, according to the results of a recent NRS-funded study comparing the bacteria found on the faces of rosacea patients and people without the condition.
The Covid-19 pandemic is omnipresent in the lives of most Americans right now.
Rosacea Awareness Month Highlights New Treatment Options for Life-Disruptive Disorder Affecting 16 Million Americans
The Saudi Journal of Ophthalmology recently published a study on the impact of rosacea on the eyes, known as ocular rosacea, which may carry implications for physicians and rosacea patients alike.
Millions of viewers worldwide tune into the Oscars broadcast every year, and from the moment actors meet photographers on the red carpet, a spotlight shines on them, showing off their glamorous appearance and highlighting any flaws or blemishes as well.
The NRS Research Grants Program has awarded funding for a new study, in addition to continued support for three ongoing studies, in its mission to help increase knowledge and understanding of the causes and other key aspects of rosacea that may lead to improvement in its management, prevention or potential cure.
The holiday season is here and so are the numerous social engagements and family events that mark this time of year.
Eggnog, mulled wine and hot cider are often regular attendees at events like this. For some, an initial pit stop at the bar before mingling can ease social anxiety, and grabbing a refill is a great excuse for a break in conversation.
More than two decades ago, rosacea was a poorly understood condition that was often considered a rare disease. Today it is estimated that more than 16 million Americans suffer from its conspicuous and embarrassing signs and symptoms, and the good news is that the advancement of scientific knowledge and treatment of rosacea has kept pace with its far wider recognition.
Makeup and skincare products may sometimes seem intimidating or downright risky for someone dealing with sensitive skin, but the ability to safely disguise rosacea’s symptoms can be an empowering weapon in the arsenal of any rosacea patient.
Sometimes there’s some truth to the myth. The red, swollen and bumpy nose of rhinophyma (pronounced “rye-no-FY-muh”) was long associated in popular discourse with heavy alcohol consumption; it’s been historically referred to as drinker’s nose, and W.C.
The National Rosacea Society has introduced an innovative public service booklet called “Recognizing Redness” to help rosacea sufferers assess facial redness, the primary diagnostic feature of this chronic facial skin disorder that affects more than 16 million Americans.
The American Cancer Society estimates that nearly 3.5 million Americans will be diagnosed with skin cancer in 2019, making this risk associated with sun exposure a very compelling reason for protecting yourself from the sun. Yet for rosacea patients there is even more reason for sun protection, as sun exposure is one of the most common triggers for rosacea flare-ups.
Inflammatory acne and rosacea are both common in Latin Americans, but because rosacea is usually associated with lighter skin tones, it is often missed or misdiagnosed in those with darker skin, according to a recent article in the Journal of Drugs in Dermatology.
After a rosacea flare-up, have you turned to the backs of product bottles to determine what may have irritated your skin, and discovered an acid listed as a major component? That’s not necessarily a bad thing.
A recent National Rosacea Society (NRS) survey found that highly successful medical treatment for rosacea often has a major positive impact on patients’ lives.
A new advance in the understanding of mast cells, located at the interface between the nervous and vascular systems, in the development of rosacea is at the center of a recent study funded by a National Rosacea Society research grant and conducted by a team led by Dr. Anna Di Nardo, professor of medicine at the University of California-San Diego.
“I want to ask the question, who on earth wants to be nearly clear if they can be clear?” asked Dr. Hilary Baldwin, associate professor of dermatology at Rutgers Robert Wood Johnson Medical School, at the start of a presentation on the importance of achieving full remission in rosacea at the American Academy of Dermatology annual meeting in March.